193 related articles for article (PubMed ID: 19492584)
1. Activating TSH-receptor mutation (Met453Thr) as a cause of adenomatous non-autoimmune hyperthyroidism in a 3-year-old boy.
Kraemer S; Rothe K; Pfaeffle R; Fuehrer-Sakel D; Till H; Muensterer OJ
J Pediatr Endocrinol Metab; 2009 Mar; 22(3):269-74. PubMed ID: 19492584
[TBL] [Abstract][Full Text] [Related]
2. Two rare TSH receptor amino acid substitutions in toxic thyroid adenomas.
Nanba K; Usui T; Minamiguchi S; Mori Y; Watanabe Y; Honda K; Asato R; Nakao K; Kawashima ST; Yuno A; Tamanaha T; Tagami T; Naruse M; Akiyama Y; Shimatsu A
Endocr J; 2012; 59(1):13-9. PubMed ID: 22001338
[TBL] [Abstract][Full Text] [Related]
3. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
Paschke R
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
[TBL] [Abstract][Full Text] [Related]
4. Genetic hyperthyroidism: hyperthyroidism due to activating TSHR mutations.
Hébrant A; van Staveren WC; Maenhaut C; Dumont JE; Leclère J
Eur J Endocrinol; 2011 Jan; 164(1):1-9. PubMed ID: 20926595
[TBL] [Abstract][Full Text] [Related]
5. Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.
Kopp P; Muirhead S; Jourdain N; Gu WX; Jameson JL; Rodd C
J Clin Invest; 1997 Sep; 100(6):1634-9. PubMed ID: 9294132
[TBL] [Abstract][Full Text] [Related]
6. Sporadic nonautoimmune congenital hyperthyroidism due to a strong activating mutation of the thyrotropin receptor gene.
Tonacchera M; Agretti P; Rosellini V; Ceccarini G; Perri A; Zampolli M; Longhi R; Larizza D; Pinchera A; Vitti P; Chiovato L
Thyroid; 2000 Oct; 10(10):859-63. PubMed ID: 11081252
[TBL] [Abstract][Full Text] [Related]
7. Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.
Führer D; Wonerow P; Willgerodt H; Paschke R
J Clin Endocrinol Metab; 1997 Dec; 82(12):4234-8. PubMed ID: 9398746
[TBL] [Abstract][Full Text] [Related]
8. Severe congenital hyperthyroidism caused by a germ-line neo mutation in the extracellular portion of the thyrotropin receptor.
Grüters A; Schöneberg T; Biebermann H; Krude H; Krohn HP; Dralle H; Gudermann T
J Clin Endocrinol Metab; 1998 May; 83(5):1431-6. PubMed ID: 9589634
[TBL] [Abstract][Full Text] [Related]
9. A somatic gain-of-function mutation in the thyrotropin receptor gene producing a toxic adenoma in an infant.
Kohn B; Grasberger H; Lam LL; Ferrara AM; Refetoff S
Thyroid; 2009 Feb; 19(2):187-91. PubMed ID: 19191749
[TBL] [Abstract][Full Text] [Related]
10. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
Kosugi S
Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
[TBL] [Abstract][Full Text] [Related]
11. Hyperfunctioning thyroid adenoma and activating mutations in the TSH receptor gene.
Polak M
Arch Med Res; 1999; 30(6):510-3. PubMed ID: 10714365
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
Castro I; Lima L; Seoane R; Lado-Abeal J
Thyroid; 2009 Jun; 19(6):645-9. PubMed ID: 19499991
[TBL] [Abstract][Full Text] [Related]
13. Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation.
Vaidya B; Campbell V; Tripp JH; Spyer G; Hattersley AT; Ellard S
Clin Endocrinol (Oxf); 2004 Jun; 60(6):711-8. PubMed ID: 15163335
[TBL] [Abstract][Full Text] [Related]
14. [Activating mutations of the TSH receptor: a synthesis highlighting certain pediatric aspects].
Polak M
Arch Pediatr; 1998; 5 Suppl 4():375S-379S. PubMed ID: 9853087
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain.
Palos-Paz F; Perez-Guerra O; Cameselle-Teijeiro J; Rueda-Chimeno C; Barreiro-Morandeira F; Lado-Abeal J; ; Araujo Vilar D; Argueso R; Barca O; Botana M; Cabezas-Agrícola JM; Catalina P; Dominguez Gerpe L; Fernandez T; Mato A; Nuño A; Penin M; Victoria B
Eur J Endocrinol; 2008 Nov; 159(5):623-31. PubMed ID: 18694911
[TBL] [Abstract][Full Text] [Related]
16. Hyperthyroidism caused by a germline activating mutation of the thyrotropin receptor gene: difficulties in diagnosis and therapy.
Bertalan R; Sallai A; Sólyom J; Lotz G; Szabó I; Kovács B; Szabó E; Patócs A; Rácz K
Thyroid; 2010 Mar; 20(3):327-32. PubMed ID: 20146656
[TBL] [Abstract][Full Text] [Related]
17. Mini-invasive videoassisted thyroid lobectomy for neonatal hyperfunctioning adenoma related to a somatic TSHr gene mutation.
Stocco E; Pelizzo MR; Grassetto G; Pagetta C; Larizza D; Massaro A; Marzola MC; Rubello D
Ann Endocrinol (Paris); 2012 Jun; 73(3):230-2. PubMed ID: 22503667
[TBL] [Abstract][Full Text] [Related]
18. Utility of systematic TSHR gene testing in adults with hyperthyroidism lacking overt autoimmunity and diffuse uptake on thyroid scintigraphy.
Patel KA; Knight B; Aziz A; Babiker T; Tamar A; Findlay J; Cox S; Dimitropoulos I; Tysoe C; Panicker V; Vaidya B
Clin Endocrinol (Oxf); 2019 Feb; 90(2):328-333. PubMed ID: 30372544
[TBL] [Abstract][Full Text] [Related]
19. Novel germline mutation (Leu512Met) in the thyrotropin receptor gene (TSHR) leading to sporadic non-autoimmune hyperthyroidism.
Roberts SA; Moon JE; Dauber A; Smith JR
J Pediatr Endocrinol Metab; 2017 Mar; 30(3):343-347. PubMed ID: 28195550
[TBL] [Abstract][Full Text] [Related]
20. [TSH receptor double mutation in functional autonomic thyroid nodule].
Semlitsch G; Höfler G; Langsteger W; Lax S; Zatloukal K; Berger A; Eber O
Acta Med Austriaca; 1995; 22(4):75-7. PubMed ID: 8835426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
